Transgenic drug production company PPL Therapeutics has been rocked
by a decision by Germany's Bayer to walk away from their protein
development partnership, placing the future of the Scottish firm at
Pfizer has announced plans to dramatically cut production
capacities at Pharmacia's factory in Tsukuba, north of Tokyo, in
order to improve profitability when the two firms merge their
Japanese operations in August
Switzerland's Bachem SA, which specialises in the manufacture and
sale of bulk peptides and related organic chemicals as active
ingredients for the pharmaceutical industry, has announced that it
expects full-year sales growth...
Belgian pharmaceuticals and chemicals group UCB has said it expects
its profit in 2003 to be at a level comparable to those of the
previous year, influenced by the unfavourable economic climate, but
especially affected by the fall...